Get in touch with PainChek

Whether you’re ready to request a demo, explore pricing, or ask a question, our team is here to help.

Prefer to talk directly? Call 1 800 720 7504 or email:
Nick Garofoli, our Head of Business Development – US at [email protected]
David Allsopp, Head of Business Development, North America at [email protected]

Prefer to talk directly?
Call 1 800 720 7504 or
email Nick Garofoli, our
Head of Business Development – US
at [email protected].

PainChek® meets regulatory standards for use in Australia, New Zealand, Canada, Singapore, Malaysia, the United Kingdom, the European Union, and PainChek® Adult has been granted a De Novo classification by the US Food and Drug Administration (FDA) for its PainChek® Adult App. The FDA De Novo Grant number is DEN240073. The tool is included in the Australian Register of Therapeutic Goods (ARTG) under ARTG number 302794.

PainChek® is a registered trade mark of PainChek in Australia, the United Kingdom, the European Union, and a trade mark in other jurisdictions.

Privacy Policy | Data Consent Policy | Terms of Service

Chat with us

Privacy Preference Center

Privacy Preferences